Construction of a Vibrio cholerae vaccine candidate using transposon delivery and FLP recombinase-mediated excision.
Recent efforts to develop a vaccine against the diarrheal disease cholera have focused on the use of live attenuated strains of the causative organism, Vibrio cholerae. The Ogawa lipopolysaccharide phenotype is expressed by many epidemic strains, and motility defects reduce the risk of reactive diarrhea in vaccine recipients. We therefore converted a motile Inaba(+) vaccine candidate, Peru-2, to a nonmotile Ogawa(+) phenotype using a mariner-based transposon carrying rfbT, the gene required for expression of the Ogawa phenotype. Analysis of 22 nonmotile Peru-2 mutants showed that two were Ogawa(+), and both of these strains had insertions in the flgE gene. It was possible to convert these strains to antibiotic sensitivity by introducing a recombinase that acts on sites flanking the antibiotic marker on the transposon. The resulting strains are competent for colonization in infant mice and may therefore be suitable as vaccine candidates for use either independently or in a combination with strains of different biotypes and serotypes.
Chiang
S L
SL
Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA.
Mekalanos
J J
JJ
D000818:Animals; D001426:Bacterial Proteins / Q000235:genetics; D002701:Chloramphenicol / Q000494:pharmacology; D022121:Cholera Vaccines; D004254:DNA Nucleotidyltransferases / Q000502:physiology*; D004251:DNA Transposable Elements; D005816:Genetic Complementation Test; D051379:Mice; D014734:Vibrio cholerae / Q000276:immunology*
D001426:Bacterial Proteins; D022121:Cholera Vaccines; D004251:DNA Transposable Elements; C082559:RfbT protein, Vibrio cholerae; D002701:Chloramphenicol; D004254:DNA Nucleotidyltransferases; C045119:FLP recombinase